Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biodesix Inc (NQ: BDSX )

1.800 +0.060 (+3.45%)
Streaming Delayed Price Updated: 9:57 AM EDT, Sep 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,941
Open 1.775
Bid (Size) 1.780 (6)
Ask (Size) 1.800 (7)
Prev. Close 1.740
Today's Range 1.775 - 1.800
52wk Range 1.150 - 2.210
Shares Outstanding 78,614,114
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Biodesix to Present at Two Investor Conferences in September
From Biodesix, Inc.
Via Business Wire
BDSX Stock Earnings: Biodesix Beats EPS, Beats Revenue for Q2 2024
BDSX stock results show that Biodesix beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace

Performance

YTD
+1.12%
+1.12%
1 Month
+0.56%
+0.56%
3 Month
+11.80%
+11.80%
6 Month
+33.33%
+33.33%
1 Year
+24.14%
+24.14%

More News

Read More
Biodesix Announces Second Quarter 2024 Results and Highlights
From Biodesix, Inc.
Via Business Wire
Biodesix to Present at Canaccord Genuity’s 44th Annual Growth Conference
From Biodesix, Inc.
Via Business Wire
Biodesix Reports 65% Growth In Lung Diagnostic Test Volume In Q4
Via Talk Markets
Biodesix: Q4 Earnings Insights
Via Benzinga
Biodesix to Report Second Quarter 2024 Financial Results on August 7, 2024
From Biodesix, Inc.
Via Business Wire
Biodesix Named to Inc. Magazine’s 2024 “Best Workplaces”
From Biodesix, Inc.
Via Business Wire
Biodesix to Participate in Two Investor Conferences in June
From Biodesix, Inc.
Via Business Wire
Biodesix's Earnings Outlook
Via Benzinga
Biodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual Meeting
From Biodesix, Inc.
Via Business Wire
BDSX Stock Earnings: Biodesix Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management
From Biodesix, Inc.
Via Business Wire
Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference
From Biodesix, Inc.
Via Business Wire
Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024
From Biodesix, Inc.
Via Business Wire
Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting
From Biodesix, Inc.
Via Business Wire
S&P 500 Gains Over 1%; GCT Semiconductor Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Gold Surges Over 1%; Biodesix Shares Plummet
Via Benzinga
Topics Stocks
Exposures US Equities
Dow Jumps Over 100 Points; US Economy Adds 303,000 Jobs In March
Via Benzinga
Topics Economy Stocks
Exposures Economy US Equities
Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement
From Biodesix, Inc.
Via Business Wire
Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center
From Biodesix, Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Earnings Scheduled For March 1, 2024
Via Benzinga
Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights
From Biodesix, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.